Curaleaf Reports Third Quarter 2026 Results: Record Revenue and Robust Profitability
PR Newswire•03/11/2026•16:01 ET
0
Key Highlights
- ➤Q3 net revenue $352.7 million, up 10.9% year over year
- ➤Q3 adjusted EBITDA $77.6 million, with a 22.0% margin
- ➤Q3 net loss from continuing operations totaled $37.4 million, or $0.14 per share
- ➤International revenue $58.7 million, up 28% year over year
- ➤Curaleaf enhanced its Aurora Cannabis takeover offer as Aurora evaluated Organigram merger
Expert Statements
Boris Jordan, Chairman and CEO of Curaleaf Holdings
“We are building the global leader in cannabis, and our third-quarter results provide further evidence that our strategy is delivering. Solid execution across the business is driving growth, strengthening our competitive position, and advancing our Built for Growth plan. Against a backdrop of increasing pressure on the consumer, cannabis demand remained resilient and our business delivered strong, broad-based growth. Record third quarter revenue of $353 million grew 11% compared to last year, bolstered by both our domestic and international segments that grew 8% and 28%, respectively. Our U.S. business has sustained the momentum experienced in the first half of the year as this was our third consecutive quarter of domestic year-over-year growth. Adjusted gross margin was 49% and adjusted EBITDA was $78 million, representing a 22% margin. We ended the quarter with $105 million in cash on the balance sheet. Cash flow from continuing operations in the quarter was $22 million, due to timing differences that will reverse next quarter. We continue to target generating approximately $150 million in operating cash flow for the year.”
Boris Jordan, Chairman and CEO of Curaleaf Holdings
“These results reflect the disciplined execution of our entire team and reinforce the strength of our global platform. We are translating operational improvements into stronger financial performance, building momentum across the business, and positioning Curaleaf for sustained growth and greater cash generation.”
Curaleaf Reports Third Quarter 2026 Results: Record Revenue and Robust Profitability PR Newswire
STAMFORD, Conn., Nov. 3, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer and medical cannabis products, today reported its financial and operating results for the third quarter ended September 30, 2026. All financial information is reported in accordance with U.S. generally accepted accounting principles ("U.S. GAAP" or "GAAP") and is provided in U.S. dollars unless otherwise indicated.
Get started
Create a free account to read the full story.
